comparemela.com

Latest Breaking News On - Elikon venture - Page 1 : comparemela.com

Innovac raises funding for lead programmes development

Innovac Therapeutics has raised $18m in Series Pre-A financing for funding the development of its lead programmes and manufacturing capabilities.

David bernsteinNicholas valianteMichael zhangShan luElaine mardisTg sino dragon fundDragon fundYunion healthcare venturesVision plus capitalElikon ventureSeries pre a

Innovac Therapeutics Closes $18M Series Pre-A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesShan luElaine mardisNicholas valianteMichael zhangDavid bernsteinTg sino dragon fundInnovac therapeuticsSeries pre aElikon ventureVision plus capitalYunion healthcare venturesDragon fundChief scientific officer

Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities

/PRNewswire/ Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18 million Series Pre-A financing. The financing.

United statesOhio state universityShan luUniversity of massachusetts medical schoolMichael zhangNicholas valianteDavid bernsteinElaine mardisGamble program at cincinnati children hospitalTemasek holdingsUniversity of cincinati department pediatricsOhio state university college of medicineUmass chan medical schoolTg sino dragon fundLaboratory of nucleic acid vaccinesSeries pre a

China Digest: Eccogene, UDS, Emposat snap funding

China Digest: Eccogene, UDS, Emposat snap funding
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Shang qiChina generalTaicanggang hongrun private equity fund managementTechnology investmentValliance capitalNew alliance capitalZhongguancun science parkZhangjiang healthcare ventureRockbleu capitalYufu investmentHuajin capitalElikon ventureDelos capitalOriza seed capitalQingsong capitalShanghai zhangjiang science

Eccogene Raises CNY 180 Million in Series B Equity Financing, Propelling its Pipeline of Treatments for Metabolic Diseases

/PRNewswire/ Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, today announced a CNY.

United statesJingye zhouEccogene incValliance capitalNew alliance capitalZhangjiang healthcare ventureRockbleu capitalYufu investmentHuajin capitalElikon ventureDelos capitalOriza seed capitalChief executive officer

vimarsana © 2020. All Rights Reserved.